Alexander Lobo
Investor Relations, Stern Investor Relations
Replay available
Inhibikase Therapeutics, Inc. (IKT) Q1 2023 Earnings Call
Inhibikase Therapeutics, Inc. (NASDAQ: IKT) Q1 2023 earnings conference call, held 2023-05-16. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Joseph Frateroli
Chief Financial Officer
Ed White
Analyst, HC Wainwright & Co.
Dr. Milton Werner
Chief Executive Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Inhibikase Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:03.215 Good morning and welcome to the Inhibitase 00:00:03.215 -- 00:00:06.849 Therapeutics First Quarter 2023 00:00:07.203 -- 00:00:12.307 Financial Results Conference Call. All participants will be in listen-only mode. 00:00:12.307 -- 00:00:17.771 Should you need assistance, please signal a comfort specialist by pressing star 00:00:17.771 -- 00:00:22.994 then zero on your telephone keypad. After today's presentation, 00:00:22.994 -- 00:00:25.956 there will be an opportunity to ask questions. 00:00:25.956 -- 00:00:31.740 To ask a question, you may press star then one on your telephone keypad. 00:00:31.740 -- 00:00:35.883 To withdraw your question, please press star then two. 00:00:35.883 -- 00:00:41.026 Please note this event is being recorded. I would now like to turn the conference 00:00:41.026 -- 00:00:45.108 over to Alexander Lobo with Stern Investor Relations. 00:00:45.108 -- 00:00:47.608 Please go ahead. 00:00:49.090 -- 00:00:51.812 Thank you. Good morning, everyone. 00:00:51.812 -- 00:00:57.114 With me today is Dr. Milton Werner, Chief Executive Officer, and Joseph Frateroli, 00:00:57.114 -- 00:00:59.536 Chief Financial Officer. 00:00:59.536 -- 00:01:05.058 On Monday, May 15, 2023, Inhibit Case issued a press release announcing financial results 00:01:05.058 -- 00:01:08.449 for the first quarter ended March 31, 2023. 00:01:09.158 -- 00:01:13.800 We encourage everyone to read yesterday's press release as well as Inhibit Case's quarterly 00:01:13.800 -- 00:01:19.103 report on Form 10-Q, which has been filed with the SEC. 00:01:19.103 -- 00:01:22.765 The company's press release and quarterly report are also available on Inhibit Case's 00:01:22.765 -- 00:01:25.785 website at inhibitcase.com. 00:01:26.347 -- 00:01:30.349 In addition, t...